Similarly, Xue et al., when analyzing both type 1 and type 2 diabetes, found no overall TIR difference; yet subgroup analyses revealed significantly higher TIR in insulin‐naïve type 2 patients, suggesting that weekly dosing may confer selective benefits depending on population characteristics [39]. The gene discussed is INS; the disease is type 2 diabetes mellitus.